Subxiphoid thoracoscopic thymectomy in a young female with seropositive Myasthenia Gravis: A case report

Authors

  • Manoj Tiwari Thoracic Unit, Dept of Surgical Oncology B P Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Binay Thakur
  • Zhenqing Shun Thoracic Unit, Dept of Surgical Oncology B P Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Sagar Khatiwada Thoracic Unit, Dept of Surgical Oncology B P Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Sachee Bhattarai Thoracic Unit, Dept of Surgical Oncology B P Koirala Memorial Cancer Hospital, Bharatpur, Nepal

DOI:

https://doi.org/10.3126/njc.v8i1.68241

Keywords:

Myasthenia gravis, Thymectomy,, Autoimmune disease

Abstract

Case: Myasthenia Gravis (MG) is an autoimmune disease that occurs at the neuromuscular junction and characterized by weakness of voluntary skeletal muscles which may be generalized or localized with an incidence of 4.1 to 30 cases per million person-years. MG is diagnosed clinically and by measuring the level of acetylcholine receptor antibodies, Muscle specific kinase antibodies and Low-density lipoprotein receptor related protein-4 antibodies. Patient is managed conservatively with cholinesterase inhibitor (pyridostigmine), prednisone, Mycophenolate mofetil and surgically by thymectomy. Here we present a case of a 27-year female who was known case of seropositive Myasthenia gravis for five years who underwent a novel technique of subxiphoid thymectomy. 

Downloads

Download data is not yet available.
Abstract
91
PDF
76
Cover NJC

Downloads

Published

2024-07-30

How to Cite

Tiwari, M., Thakur, B., Shun, Z., Khatiwada, S., & Bhattarai, S. (2024). Subxiphoid thoracoscopic thymectomy in a young female with seropositive Myasthenia Gravis: A case report. Nepalese Journal of Cancer, 8(1), 71–75. https://doi.org/10.3126/njc.v8i1.68241

Issue

Vol. 8 No. 1 (2024)

Section

Case Reports

License

Copyright (c) 2024 Nepalese Journal of Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.

Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.